Inactive Instrument

Press Releases KaloBios Pharmaceuticals Inc Nasdaq

Equities

US48344T1007

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 12	Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc.	CI
Mar. 08	Final DIP Financing Approved for Humanigen, Inc.	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CapitalGainesReport: OTC Bounce List (EPAZ, ABML, HGEN, RINO)	23-08-09	AQ
Exploring Breakthrough Biotech Stocks: ENZC, CYDY, HGEN, HALB	23-07-19	AQ
HUMANIGEN, INC : Other Events, Financial Statements and Exhibits (form 8-K)	23-04-19	AQ
HUMANIGEN, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	23-04-06	AQ
HUMANIGEN, INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-03-30	AQ
HUMANIGEN, INC : Regulation FD Disclosure (form 8-K)	23-03-13	AQ
HUMANIGEN, INC : Other Events, Financial Statements and Exhibits (form 8-K)	23-03-02	AQ
HUMANIGEN, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits (form 8-K)	23-02-24	AQ
HUMANIGEN, INC : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	22-12-22	AQ
HUMANIGEN, INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-11-14	AQ
HUMANIGEN, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	22-10-06	AQ
HUMANIGEN, INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	22-09-29	AQ
HUMANIGEN, INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	22-09-02	AQ
HUMANIGEN, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	22-08-26	AQ
Humanigen : Reports Second Quarter 2022 Financial Results - Form 8-K	22-08-12	PU
HUMANIGEN, INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-08-12	AQ
Humanigen Reports Second Quarter 2022 Financial Results	22-08-12	BU
HUMANIGEN, INC : Termination of a Material Definitive Agreement, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	22-07-26	AQ
Humanigen : receives preliminary topline data from NIH/NIAID study of lenzilumab in ACTIV-5/BET-B - Form 8-K	22-07-13	PU
HUMANIGEN, INC : Other Events, Financial Statements and Exhibits (form 8-K)	22-07-13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases KaloBios Pharmaceuticals Inc Nasdaq

Equities

US48344T1007

Press Releases

Filters